Celgene Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celgene with three other
companies in this sector in the United States:
sales of $11.08 billion
Shire Plc - adr
of which 100%
was Pharmaceuticals & Genetic Therapies), and
of which 41%
was US Medical Aesthetics).
Celgene reported sales of $11.23 billion
December of 2016.
increase of 21.3%
versus 2015, when the company's sales were $9.26 billion.
Sales at Celgene have increased during each of the previous five years
(and since 2011, sales have increased a total of 132%).